NCT02206425 2023-10-31Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma PatientsOncotherapeuticsPhase 1/2 Completed45 enrolled
NCT00103506 2015-10-19Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple MyelomaJanssen Research & Development, LLCPhase 3 Completed646 enrolled 10 charts